Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Innovation ; : 81-83, 2013.
Article in English | WPRIM | ID: wpr-631178

ABSTRACT

Cases years and leads to increase in risk of hemorrhag of blood and blood products. There is a case presentation. Patient 23 years old. primigravida. Blood pathology was diagnosed in 2003. Platelets were 25.000-35.000 before pregnancy and about 6.000 during pregnancy. She was admitted to hospital and has treatment for 20 days and undergone Cesarean section and subtotal hysterectomy. She was discharged 11 days after operation with her baby. We could prevent severe pathology that would occur for mother with severe coagulation disorder by conducting treatment directed to improve platelets release, to inhibit phagocytes activities (immunoglobulin and steroids), to compensate coagulation disorders and blood product transfusions on the basis of laboratory analyses. These treatments made possible to perform surgery and severe pathology that could arise for newborn. Many times transfusion of different blood products were transfused safely. Mother delivered without complications and she had healthy baby.

SELECTION OF CITATIONS
SEARCH DETAIL